文献速递脑血管病

低剂量阿司匹林在无症状心血管病人群中的颅内出血风险:系统综述与Meta分析

Frequency of Intracranial Hemorrhage With Low-Dose Aspirin in Individuals Without Symptomatic Cardiovascular Disease: A Systematic Review and Meta-analysis.
PubMed 文献 · JAMA Neurol · 2019-01-01

结果显示低剂量阿司匹林增加任何颅内出血风险(RR 1.37,95%CI 1.13-1.66),硬膜下或硬膜外出血风险增加最明显(RR 1.53,95%CI 1.08-2.18);亚裔或低体重指数人群脑出血风险更高。

要点

  • 低剂量阿司匹林用于一级预防增加任何颅内出血风险,每1000人约多2例。
  • 硬膜下或硬膜外出血的相对风险增加最明显(RR 1.53)。
  • 亚裔或低体重指数人群使用低剂量阿司匹林时脑出血风险更高。

核心结论

  • 在无心血管症状人群中,低剂量阿司匹林与任何颅内出血风险增加相关,亚裔或低体重指数者脑出血风险更高。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、Embase、Cochrane Central及ClinicalTrials.gov(1966年1月至2018年10月30日)。
  • 采用Mantel-Haenszel随机效应模型计算相对风险(RR)及95%CI。

主要发现

  • 低剂量阿司匹林与任何颅内出血风险增加相关(8项试验;RR 1.37;95%CI 1.13-1.66;每1000人额外2例颅内出血)。
  • 硬膜下或硬膜外出血的相对风险增加最明显(4项试验;RR 1.53;95%CI 1.08-2.18)。
  • 脑出血和蛛网膜下腔出血的风险增加相对较小。
  • 与对照相比,亚裔和低体重指数人群使用低剂量阿司匹林时脑出血风险更高。

临床怎么用

  • 对无心血管症状人群处方低剂量阿司匹林前,应评估颅内出血风险,尤其亚裔或低体重指数者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Use of low-dose aspirin for the primary prevention of cardiovascular events remains controversial because increased risk of bleeding may offset the overall benefit. Among major bleeding events, intracranial hemorrhage is associated with high mortality rates and functional dependency. OBJECTIVE: To assess the risk of intracranial hemorrhage associated with low-dose aspirin among individuals without symptomatic cardiovascular disease. DATA SOURCES: PubMed, Embase, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov were searched from January 1966 to October 30, 2018. STUDY SELECTION: Randomized clinical trials that compared low-dose aspirin (daily dose ≤100 mg) vs control and recorded the end points of intracranial hemorrhage separately for active treatment and control groups were included. DATA EXTRACTION AND SYNTHESIS: A random-effect estimate was computed based on the Mantel-Haenszel method. Relative risk with 95% CI was used as a measure of aspirin vs control on risk of intracranial hemorrhage. MAIN OUTCOMES AND MEASURES: The main outcomes were any intracranial hemorrhage, intracerebral hemorrhage, subdural or extradural hemorrhage, and subarachnoid hemorrhage, for aspirin vs control. RESULTS: The search identified 13 randomized clinical trials of low-dose aspirin use for primary prevention, enrolling 134 446 patients. Pooling the results from the random-effects model showed that low-dose aspirin, compared with control, was associated with an increased risk of any intracranial bleeding (8 trials; relative risk, 1.37; 95% CI, 1.13-1.66; 2 additional intracranial hemorrhages in 1000 people), with potentially the greatest relative risk increase for subdural or extradural hemorrhage (4 trials; relative risk, 1.53; 95% CI, 1.08-2.18) and less for intracerebral hemorrhage and subarachnoid hemorrhage. Patient baseline features associated with heightened risk of intracerebral hemorrhage with low-dose aspirin, compared with control, were Asian race/ethnicity and low body mass index. CONCLUSIONS AND RELEVANCE: Among people without symptomatic cardiovascular disease, use of low-dose aspirin was associated with an overall increased risk of intracranial hemorrhage, and heightened risk of intracerebral hemorrhage for those of Asian race/ethnicity or people with a low body mass index.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Huang WY, Saver JL, Wu YL, et al. Frequency of Intracranial Hemorrhage With Low-Dose Aspirin in Individuals Without Symptomatic Cardiovascular Disease: A Systematic Review and Meta-analysis. JAMA Neurol. 2019. PMID: 31081871. doi:10.1001/jamaneurol.2019.1120

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。